Series Description

Chronic inflammatory demyelinating polyneuropathy (CIDP) remains a challenging, heterogeneous condition—too often underdiagnosed, misdiagnosed, or managed suboptimally. The result? Preventable progression, long-term disability, and diminished quality of life. Even with established guidelines, clinicians continue to grapple with recognizing varied presentations, applying diagnostic criteria with certainty, and navigating the limitations of current therapies. And with new biologic agents on the horizon and accelerating research on immunoglobulin G (IgG) autoantibodies and disease mechanisms, staying current has never been more essential.

CIDP Masterclass: Early Diagnosis, Emerging Options, Better Outcomes is a five-part accredited CE series delivered through the dynamic Project ECHO® collaborative learning model. Designed for neurologists, neuromuscular specialists, nurse practitioners, physician associates, pharmacists, and neurology-focused nurses, this immersive program brings together foundational knowledge, real-world case discussions, and cutting-edge insights to elevate your approach to CIDP.

Participants are encouraged to join the full learning journey to gain a cohesive, practice-transforming experience—one that equips you to diagnose earlier, treat smarter, and partner with patients for improved long-term outcomes.

Credit Information

Jointly Accredited Provider

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians (ACCME)

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC)

This activity is designated for 1.0 contact hour.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

Physician Associates (AAPA)

Boston University Chobanian & Avedisian School of Medicine, has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Pharmacists (ACPE)

This application-based activity is approved for 1.0 contact hour of continuing pharmacy credit.

Certificate of Participation

This activity was certified for a maximum of 1.0 AMA PRA Category 1 Credit™. This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education Credit for learning and change.